Related Experiment Video
Updated: May 17, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Development of a protocol on safe practices for insulin preparation and administration
Tatiana Rebouças Moreira1, Rhanna Emanuela Fontenele Lima de Carvalho1, Consuelo Helena Aires de Freitas1
1Universidade Estadual do Ceará. Fortaleza, Ceará, Brazil.
Revista Brasileira De Enfermagem
|May 15, 2026
Summary
A new protocol for safe insulin preparation and administration was developed and validated. This high-quality tool significantly improved healthcare professionals' knowledge of safe insulin practices.
Area of Science:
- Healthcare Quality Improvement
- Medication Safety Protocols
- Clinical Practice Guidelines
Background:
- Insulin preparation and administration errors pose significant risks in healthcare settings.
- Standardized protocols are essential for ensuring patient safety during insulin therapy.
- Existing protocols may require validation for optimal effectiveness and adherence.
Purpose of the Study:
- To develop and validate a comprehensive protocol for the safe preparation and administration of insulin.
- To assess the quality, validity, and reproducibility of the developed insulin protocol.
- To evaluate the impact of training based on the protocol on healthcare professionals' knowledge.
Main Methods:
- A two-phase methodological study involving expert review (AGREE II) and healthcare professional training.
- Protocol development and validation by 46 experts, followed by training of 40 professionals in Brazil.
- Statistical analysis included Content Validity Index, Cronbach's alpha, McDonald's omega, and pre/post-test knowledge assessment.
Main Results:
- The protocol demonstrated high quality (95.7% overall score) and content validity (97.83-100%), with excellent reproducibility (alpha=0.94, omega=0.95).
- All six AGREE II domains scored above 90.0%, indicating robust methodological and content aspects.
- Post-training knowledge significantly increased from 32% to 70% among healthcare professionals.
Conclusions:
- The validated insulin protocol is a high-quality, reliable tool for enhancing safe medication practices.
- Implementation of this protocol effectively improves healthcare professionals' understanding and application of safe insulin procedures.
- This validated protocol represents a significant advancement in patient safety technology for insulin management.
Related Concept Videos
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...